Moderna's COVID-19 Vaccine Protects Against Delta Variant, Study Finds
Moderna's Covid-19 vaccine protects people for at least six months and likely longer -- even against new variants, researchers reported Thursday.
Watch CBS News
Moderna's Covid-19 vaccine protects people for at least six months and likely longer -- even against new variants, researchers reported Thursday.
Moderna is doubling the number of kids in its COVID-19 vaccine trial and there are three local sites that are part of the study.
Moderna says a third booster dose of its COVID-19 vaccine will likely be necessary this fall because of the rapid spread of the Delta variant of the coronavirus.
Moderna says its COVID-19 vaccine is 93-percent effective against the coronavirus six months after people get the second dose.
Many parents are eager to vaccinate younger children as schools prepare to open for in-person learning in the fall.
Moderna says "encouraging" new data backs up the belief that its two-dose COVID vaccine protects against emerging strains of the coronavirus, including the Delta variant.
CDC researchers found a "likely association" between the shots and rare cases of heart inflammation in young people.
Those doses could be used to vaccinate children in the future, if approved, or to serve as booster shots if needed.
Moderna on Thursday announced it has filed for emergency use authorization of its COVID vaccine in adolescents 12 to 17 years old.
Moderna's CEO said its COVID-19 vaccine will likely be available to children as young as five by the early fall.
At a lower dose, the company says it could stretch its supply and produce up to 300 million doses annually.
Not a single teen who received two doses of the vaccine came down with the coronavirus, the Cambridge-based biotech company said.
Moderna expects FDA approval of its COVID vaccine for children 12-17 years old is just weeks away.
"No serious safety concerns have been identified to date," Moderna said about the trial on teens.
Moderna said initial test results of its vaccine booster shot show it works against two variants of COVID-19.
The space will more than double to 650,000 square feet as Moderna ramps up production of its COVID-19 vaccine there.
Starting Monday, Boston University plans to start offering COVID vaccines to students.
Moderna says it is boosting global manufacturing of its COVID-19 vaccine hoping to deliver up to 3 billion doses in 2022.
Researchers studied 35,000 women who received either one of the shots while pregnant from December 2020 through February 2021.
A third shot is not currently required but could offer additional immunity against coronavirus variants.
Moderna said new data shows its COVID-19 vaccine continues to provide strong protection.
Moderna said it's COVID-19 vaccine offers protection for at least six months.
The FDA has approved new vials from Moderna that can contain up to 15 doses each, compared with the original vials designed to hold 10 doses.
Pfizer and Moderna vaccines were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday.
Moderna has now shipped 100 million doses of its COVID-19 vaccine to the federal government, the Cambridge-based company announced Monday.
